GGrantIndex
← Leaderboards

Steven E Patterson

University Of Minnesota

$9,957,982
Attributed
$11,759,205
Total exposure
6
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.2M · FY200622
$2.5M$1.9M$1.3M$625K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22

Funding mix

By agency

NIH$15,127,301 · 7

By mechanism

U01$7,980,846 · 2
U54$4,336,445 · 3
R01$2,377,310 · 1
R21$432,700 · 1

Top collaborators

Most similar at University Of Minnesota

Same institution · by research overlap

Others in their field

Top investigators on “Toxic Effect

Research focus

Toxic EffectCyanidesPoisoningAntidotesDoseProdrugsMilitary PersonnelEnzymesAnimal ModelLeadExposure ToSecurityAnalogBaseResearch PersonnelPharmaceutical PreparationsUnited States National Institutes Of HealthDrug CombinationsPrototypeWaterIn VivoAcuteSeriesSolutions

Grant awards (31)

Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning$662,943
U01 · FY2022 · NS · contact PI
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning$615,727
U01 · FY2021 · NS · contact PI
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning$505,514
U01 · FY2020 · NS · contact PI
Optimization of a Combined Drug and Delivery Device for Treatment of Cyanide Poisoning$571,768
U01 · FY2019 · NS · contact PI
Discovery of a novel target for giardiasis$190,700
R21 · FY2019 · AI · contact PI
Discovery of a novel target for giardiasis$242,000
R21 · FY2018 · AI · contact PI
HIV Reverse Transcriptase-Mediated Mutagenesis$578,622
R01 · FY2016 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis$578,622
R01 · FY2015 · GM
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$658,439
U01 · FY2014 · NS · contact PI
HIV Reverse Transcriptase-Mediated Mutagenesis$578,622
R01 · FY2014 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis$40,363
R01 · FY2014 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis$9,459
R01 · FY2014 · GM
HIV Reverse Transcriptase-Mediated Mutagenesis$591,622
R01 · FY2013 · GM
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$757,455
U01 · FY2012 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$759,391
U01 · FY2011 · NS · contact PI
Combined Use of Cobinamide and a 3-Mercaptopyruvate Prodrug for Cyanide Poisoning$76,408
U54 · FY2011 · NS · contact PI
Combined Use of Cobinamide and a 3-Mercaptopyruvate Prodrug for Cyanide Poisoning$981,770
U54 · FY2010 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$718,138
U01 · FY2010 · NS · contact PI
Countermeasures against cyanide$230,782
U54 · FY2010 · NS · contact PI
Administration$37,085
U54 · FY2010 · NS · contact PI
Combined Use of Cobinamide and a 3-Mercaptopyruvate Prodrug for Cyanide Poisoning$1,005,518
U54 · FY2009 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$700,591
U01 · FY2009 · NS · contact PI
Countermeasures against cyanide$302,550
U54 · FY2009 · NS · contact PI
Combined Use of Cobinamide and a 3-Mercaptopyruvate Prodrug for Cyanide Poisoning$136,000
U54 · FY2009 · NS · contact PI
Administration$41,644
U54 · FY2009 · NS · contact PI
Combined Use of Cobinamide and a 3-Mercaptopyruvate Prodrug for Cyanide Poisoning$1,168,400
U54 · FY2008 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$683,171
U01 · FY2008 · NS · contact PI
Countermeasures against cyanide$315,847
U54 · FY2008 · NS · contact PI
Administration$40,441
U54 · FY2008 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$671,375
U01 · FY2007 · NS · contact PI
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide$676,334
U01 · FY2006 · NS · contact PI